Inhaled antibiotic for lung infection in ventilated patients
Part of Infections, Lungs & breathing clinical trials.
This trial tests whether an inhaled antibiotic (amikacin) can help clear a lung infection called ventilator-associated tracheobronchitis in patients who are on a breathing machine. It may reduce infection and improve recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are currently in an intensive care unit on a breathing machine for more than 48 hours.
- You have a first lung infection during this ICU stay, confirmed by a doctor with specific tests.
- You are covered by French health insurance (Social Security).
- For women who could be pregnant, a negative pregnancy test is needed.
- You are not currently receiving certain other antibiotics or treatments that could interfere.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a nebulized (inhaled) antibiotic called colistimethate sodium can prevent ventilator-associated pneumonia (a lung infection) in children who are on a breathing machine. If it works, this could reduce the risk of serious lung infections in hospitalized children.
This trial tests an “antibiotic stewardship” approach—choosing and adjusting antibiotics in a smarter way—for a first episode of pneumonia in patients on a breathing machine. It may help ensure the right antibiotics are used at the right time, while avoiding unnecessary or overly broad treatment.
This trial tests whether using non-invasive suctioning methods (without needing to disconnect the breathing tube) can lower the risk of lung infections in critically ill patients who need a breathing tube. It may help reduce the chance of pneumonia during intensive care.
This trial tests whether adding an inhaled antibiotic (amikacin) to standard IV antibiotics can better treat a serious lung infection (pneumonia caused by Gram-negative bacteria) in patients on a heart-lung machine (ECMO) and a breathing tube. If you or your loved one is on ECMO and has this type of pneumonia, this study may offer a new treatment approach.
This trial tests whether inhaling an antibiotic called amikacin can prevent ventilator-associated pneumonia in patients with severe liver disease (cirrhosis) who are on a breathing machine. If you or your loved one is in the ICU with liver issues and needs a ventilator, this study may help reduce the risk of a serious lung infection.
This trial tests whether inhaling an antibiotic called tobramycin can prevent a serious lung infection in patients who need a breathing tube. It may help people at higher risk for difficult-to-treat infections.
Hear when a new Ventilator Associated Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.